MedTrace Logo

Lactobacillus Casei Strain Shirota Fermented Milk for Alleviating Hard Stools in Vietnam

NCT05982743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2023-08-14

No results posted yet for this study

Summary

The objective of this study is to provide evidence supporting the efficacy of fermented milk containing Lactobacillus casei strain Shirota in alleviating hard or lumpy stools. A randomized, controlled trial has been designed on constipated adults with a high prevalence of hard stools in Vietnam.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lactobacillus casei strain Shirota fermented milk

Participants will take one bottle (65 ml) of Yakult® drink daily, containing at least 6.5 x 10\^9 CFU of Lactobacillus casei strain Shirota, for a period of 4 weeks. Subsequently, there will be a two-week follow-up period.

Sponsors & Collaborators

  • Bach Mai Hospital

    collaborator OTHER

  • Vietnam National University

    collaborator OTHER

  • Yakult Honsha Co., LTD

    lead INDUSTRY

Principal Investigators

  • Vinh Van Hoang, PhD · Vietnam National University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-11
Primary Completion
2023-03-08
Completion
2023-03-08

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05982743 on ClinicalTrials.gov